Search

everythinglearnresearchcommunity

for

Search:↓

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

No significant genetic link to alopecia areata was found in the Jordanian group.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Significant progress and collaborations in stem cell research and regenerative medicine were made, including advancements in hair growth, cancer therapies, and treatments for neurological disorders.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Gut bacteria differences could help diagnose and treat alopecia areata.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Human amniotic stem cell exosomes may effectively treat hair loss by promoting hair regrowth.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

The HATMSC1 cell line from fat tissue can produce helpful factors for regenerative and immune therapies.

Microorganism overgrowth and hyperkeratosis may trigger immune reactions causing lichen planopilaris.

Engineered nanovesicles from hair follicle stem cells can effectively treat UVB-induced skin aging.

Pulse corticosteroid therapy helps many with severe alopecia areata regrow hair, but has side effects.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

More precise, personalized therapies are needed for autoimmune diseases.

Human periapical cyst stem cells could be a promising source for regenerative medicine.